SPECTRA: Spectral Target-Aware Graph Augmentation for Imbalanced Molecular Property Regression

Brenda Nogueira, Meng Jiang, Nitesh V. Chawla, & Nuno Moniz · 2025

Read SPECTRA: Spectral Target-Aware Graph Augmentation for Imbalanced Molecular Property Regression by Brenda Nogueira, Meng Jiang, Nitesh V. Chawla, & Nuno Moniz (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2511-04838.txt.

Introduction

Brenda Nogueira leads five authors with SPECTRA, a generative fix for lopsided molecular data. Property regression fails most where data are rarest, yet those rare ranges often matter most. Oversampling just copies molecules and produces meaningless variants.

SPECTRA generates fresh graphs guided by spectral structure instead. A rarity-aware budget focuses effort where examples are scarce. Target-neighbor alignment keeps new graphs structurally tied to real ones. Laplacian spectra, node features, and targets are interpolated together for each synthetic case. A spectral graph network with edge-aware filters then learns from the enriched set.

Catalog record

CREATORBrenda Nogueira, Meng Jiang, Nitesh V. Chawla, & Nuno Moniz
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
VERSION1.0
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2511-04838

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

SPECTRA: Spectral Target-Aware Graph Augmentation for Imbalanced Molecular Property Regression Brenda Nogueira, Meng Jiang, Nitesh V. Chawla, & Nuno Moniz Abstract In molecular property prediction, the most valuable compounds (e.g., high potency) often occupy sparse regions of the target space. Standard Graph Neural Networks (GNNs) commonly optimize for the average error, underperforming on these uncommon but critical cases, with existing oversampling methods often distorting molecular topology. In this paper, we introduce SPECTRA, a Spectral Target-Aware graph augmentation framework that generates realistic molecular graphs in the spectral domain. SPECTRA (i) reconstructs multi-attribute molecular graphs from SMILES; (ii) aligns molecule pairs via (Fused) Gromov–Wasserstein couplings to obtain node correspondences; (iii) interpolates Laplacian eigenvalues/eigenvectors and node features in a stable shared basis; and (iv) reconstructs edges to synthesize physically plausible intermediates with interpolated targets. A rarity-aware budgeting scheme, derived from a kernel density estimation of labels, concentrates augmentation where data are scarce. Coupled with a spectral GNN using edge-aware Chebyshev convolutions, SPECTRA densifies underrepresented regions without degrading global accuracy. On benchmarks, SPECTRA consistently improves error in relevant target ranges while maintaining competitive overall MAE, and yields interpretable synthetic molecules whose structure reflects the underlying spectral geometry. Our results demonstrate that spectral, geometry-aware augmentation is an effective and efficient strategy for imbalanced molecular property regression. 1 Introduction Graph-structured data plays a central role in many scientific domains, including drug discovery, materials science, and genomics. These fields produce large volumes of complex, structured information that can be naturally represented as graphs, where nodes correspond to entities (e.g., atoms, molecules, genes) and edges capture their relationships (e.g., chemical bonds, interactions). Graph Neural Networks (GNNs) have transformed the modeling of such data by operating directly on graph structures, enabling state-of-the-art predictions of molecular properties, material characteristics, and biological interactions. In drug discovery, for example, GNNs have been applied to property prediction ( Xiong et al. 2020 ) , molecular design ( Jin et al. 2018 ) , and drug–target interaction prediction ( Lim et al. 2019 ) , with increasing adoption by the pharmaceutical industry to accelerate a development pipeline that typically exceeds $1 billion and a decade of effort ( Vamathevan et al. 2019 ) . Similar advances have been reported in materials science, where GNNs help identify compounds with desirable structural and functional properties ( Karamad et al. 2020 ) . Despite this progress, a fundamental challenge remains largely unsolved: imbalanced regression on graphs. While imbalanced classification has received significant attention in graph learning, the regression setting has been comparatively neglected ( Almeida et al. 2024 ; Xia et al. 2024 ; Ribeiro & Moniz 2020a ; Liu et al. 2023b ) . Yet, many scientific problems involve continuous targets where the most valuable outcomes are rare. Standard GNNs and other machine learning methods typically optimize for average performance across the full label distribution, which leads to poor accuracy in these rare but scientifically important regions. Classical oversampling techniques can mitigate imbalance but often fail to preserve the intricate topological and chemical properties of molecular graphs, limiting their practical effectiveness. Another limitation lies in embedding-based augmentation methods , which often generate synthetic molecules in latent spaces that lack interpretability and offer no guarantees of structural validity. As a result, the augmented samples may not correspond to chemically realistic molecules, hindering trust and practical adoption. To address these challenges, we propose SPECTRA — Spectral Target-Aware Graph Augmentation for Imbalanced Molecular Property Regression . SPECTRA introduces a novel approach to oversampling that operates directly in the spectral domain of graphs. Specifically, it leverages the eigenspace of the graph Laplacian to interpolate both Laplacian spectra and node features of matched graphs in a shared spectral basis. This process produces synthetic molecular graphs that are structurally coherent, chemically plausible, and explicitly tailored to underrepresented regions of the target distribution 1 . Unlike black-box embedding methods, SPECTRA provides interpretability by generating realistic molecules whose structures can be directly examined, while achieving significantly lower computational cost compared to existing state-of-the-art techniques. Our contributions can be summarized as follows: • Novel methodology. We introduce a spectral augmentation framework that augments samples in low-density regions of the label space while preserving topological fidelity, overcoming the limitations of existing oversampling techniques in regression. • Improved predictive performance. Across benchmark molecular property datasets, SPECTRA achieves low error on rare compounds without degrading performance on common cases. • Interpretability and efficiency. The synthetic graphs generated by SPECTRA are realistic and chemically meaningful, enabling direct inspection of augmented molecules while maintaining a lower computational footprint compared to competing approaches. Together, these findings demonstrate that spectral graph augmentation is an effective and interpretable strategy for tackling imbalanced regression in molecular property prediction. The code and dataset are available in https://anonymous.4open.science/r/SPECTRA-0D3C Figure 1: Distribution of target property values across three molecular datasets (ESOL, FreeSolv, and Lipo). Each subplot shows a normalized histogram of the experimental values with a Gaussian kernel density estimate (KDE) overlaid using Scott’s rule-of-thumb bandwidth. These plots highlight the skewness and spread of target distributions, which can influence model training and performance. 2 Related Work The challenge of imbalanced distributions in graph learning tasks has received increasing attention, particularly in scientific domains where rare values are critical. Recent research by Almeida et al. 2024 demonstrates that imbalanced learning in drug discovery datasets can be tackled with techniques such as oversampling and loss function manipulation when using Graph Neural Networks (GNNs). Despite these advances, most approaches operate directly in graph space rather than the spectral domain, limiting their ability to maintain global structural constraints. Bo et al. 2023b published a comprehensive survey on spectral GNNs, highlighting their unique ability to capture global information and provide better expressiveness than spatial approaches. Wang & Zhang 2022 further analyzed the theoretical expressive power of spectral GNNs, proving that they can produce arbitrary graph signals under specific conditions. However, these methods focus on balanced and classification datasets, illustrating the novelty and significance of SPECTRA. 2.1 Imbalanced Learning Class imbalance has traditionally been addressed through resampling strategies, such as under-sampling majority classes or over-sampling minority classes. SMOTE ( Chawla et al. 2002 ) , for instance, generates synthetic minority samples by interpolating labeled data. Alternative approaches include cost-sensitive learning ( Cui et al. 2019 ; Lin et al. 2017 ) , which increases the loss weight of minority classes, and posterior re-calibration ( Cao et al. 2019 ; Menon et al. 2020 ; Tian et al. 2020 ) , which encourages larger margins for minority predictions. Imbalanced regression introduces additional challenges because the labels are continuous rather than categorical ( Ribeiro & Moniz 2020a ) . Several methods from classification have been adapted to this setting. For example, SMOGN Branco et al. 2017 extends SMOTE to regression, while BMSE Ren et al. 2022 adapts logit re-calibration for numerical targets. LDS Yang et al. 2021 smooths the label distribution using kernel density estimation, and RankSim Gong et al. 2022 regularizes the latent space by aligning distances in label and feature space. Other approaches include SERA Ribeiro & Moniz 2020b , which proposes a relevance-aware evaluation metric; SGIR Liu et al. 2023a , which leverages unlabeled graphs to enrich underrepresented label ranges; and SIRN Zong et al. 2024 , which combines deviation modeling with

Read the complete text